Cameroun < Canada < Chili

Facettes :

List of bibliographic references

Number of relevant bibliographic references: 3256.
[0-20] [0 - 20][0 - 50][20-40]

Ident.	Authors (with country if any)	Title
000001 (1999)	R E Gross [Canada] ; W J Lombardi ; W D Hutchison ; S. Narula ; J A Saint-Cyr ; J O Dostrovsky ; R R Tasker ; A E Lang ; A M Lozano	Variability in lesion location after microelectrode-guided pallidotomy for Parkinson's disease: anatomical, physiological, and technical factors that determine lesion distribution.
000002 (1999)	R. Edwards [Canada] ; A. Beuter ; L. Glass	Parkinsonian tremor and simplification in network dynamics.
000003 (1998)	E. Jaeggi [Canada] ; J C Fouron ; A. Fournier ; N. Van Doesburg ; S P Drblik ; F. Proulx	Ventriculo-atrial time interval measured on M mode echocardiography: a determining element in diagnosis, treatment, and prognosis of fetal supraventricular tachycardia.
000004 (1999)	R. Grondin [Canada] ; V D Doan ; L. Grégoire ; P J Bédard	D1 receptor blockade improves L-dopa-induced dyskinesia but worsens parkinsonism in MPTP monkeys.
000005 (1998)	A. Hadj Tahar [Canada] ; P J Bédard	[Understanding and treating levodopa-induced dyskinesias].
000006 (1999)	R E Gross [Canada] ; W J Lombardi ; A E Lang ; J. Duff ; W D Hutchison ; J A Saint-Cyr ; R R Tasker ; A M Lozano	Relationship of lesion location to clinical outcome following microelectrode-guided pallidotomy for Parkinson's disease.
000007 (1999)	A. Samii [Canada] ; I M Turnbull ; A. Kishore ; M. Schulzer ; E. Mak ; S. Yardley ; D B Calne	Reassessment of unilateral pallidotomy in Parkinson's disease. A 2-year follow-up study.
000008 (1999)	T A Reader [Canada] ; K M Dewar	Effects of denervation and hyperinnervation on dopamine and serotonin systems in the rat neostriatum: implications for human Parkinson's disease.
000009 (1999)	C P Granvil [Canada] ; A. Madan ; M. Sharkawi ; A. Parkinson ; I W Wainer	Role of CYP2B6 and CYP3A4 in the in vitro N-dechloroethylation of (R)- and (S)-ifosfamide in human liver microsomes.
000010 (1992)	D K Martin [Canada]	Foetal tissue transplantation research: a Canadian policy analysis.
000011 (1990)	G M Bray [Canada]	Neural transplantation.
000012 (1998)	D. Hailey [Canada] ; C. Harstall	Posteroventral pallidotomy for Parkinson's disease: assessment and policy on a technology in transition.
000014 (1999)	A F Miranda [Canada] ; M A Sutton ; R J Beninger ; K. Jhamandas ; R J Boegman	Quinolinic acid lesion of the nigrostriatal pathway: effect on turning behaviour and protection by elevation of endogenous kynurenic acid in Rattus norvegicus.
000015 (1999)	M. Ichise [Canada] ; Y J Kim ; S S Erami ; J R Ballinger ; D. Vines ; F. Tanaka ; A E Lang	Functional morphometry of the striatum in Parkinson's disease on three-dimensional surface display of 123I-beta-CIT SPECT data.
000016 (1999)	M. Ichise [Canada] ; Y J Kim ; J R Ballinger ; D. Vines ; S S Erami ; F. Tanaka ; A E Lang	SPECT imaging of pre- and postsynaptic dopaminergic alterations in L-dopa-untreated PD.
000019 (1998)	S L Borgland [Canada] ; M. Casta N ; W. Spevak ; F E Parkinson	Effects of propentofylline on adenosine receptor activity in Chinese hamster ovary cell lines transfected with human A1, A2A, or A2B receptors and a luciferase reporter gene.
000020 (1999)	R. Grondin [Canada] ; P J Bédard ; A. Hadj Tahar ; L. Grégoire ; A. Mori ; H. Kase	Antiparkinsonian effect of a new selective adenosine A2A receptor antagonist in MPTP-treated monkeys.
000022 (1999)	V. Radhakrishnan [Canada] ; J. Tsoukatos ; K D Davis ; R R Tasker ; A M Lozano ; J O Dostrovsky	A comparison of the burst activity of lateral thalamic neurons in chronic pain and non-pain patients.
000023 (1999)	A S Pakiam [Canada] ; C. Bergeron ; A E Lang	Diffuse Lewy body disease presenting as multiple system atrophy.
000024 (1999)	D C Vines [Canada] ; B D Ivo ; J R Ballinger ; M. Ichise	External radioactive reference markers in SPECT imaging of the dopamine system.
000025 (1999)	Z S Nasreddine [Canada] ; M. Loginov ; L N Clark ; J. Lamarche ; B L Miller ; A. Lamontagne ; V. Zhukareva ; V M Lee ; K C Wilhelmsen ; D H Geschwind	From genotype to phenotype: a clinical pathological, and biochemical investigation of frontotemporal dementia and parkinsonism (FTDP-17) caused by the P301L tau mutation.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Ncbi/Checkpoint

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/AffPays.i -k "Canada" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/AffPays.i  \
                -Sk "Canada" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Ncbi
   |étape=   Checkpoint
   |type=    indexItem
   |index=    AffPays.i
   |clé=    Canada
}}

---

This area was generated with Dilib version V0.6.29. Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022